Podme logo
HjemOppdagKategorierSøkStudent
BioBullets: The Aduhelm FDA approval controversy

BioBullets: The Aduhelm FDA approval controversy

10:132021-08-13

Om episode

This podcast accompanies Horizon 3 Biotech's BioBullets email for the 13th August 2021

Nyeste episoder

Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2022-06-2237min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2022-06-011h 2min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2022-03-2149min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2022-02-1034min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2021-12-2231min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2021-11-0842min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2021-10-2635min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

BioBullets: The Great Dispersion

2021-09-1713min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2021-09-1337min
logo

PODME

INFORMASJON

  • Om informasjonskapsler
  • Generelle vilkår
  • Personvernerklæring

LAST NED APPEN

app storegoogle play store

REGION

flag
  • sweden_flag
  • norway_flag
  • finland_flag
redaktorsansvar

Podme arbeider etter Vær Varsom-plakatens regler for god presseskikk. Ansvarlig redaktør og daglig leder er Kristin Ward Heimdal. Redaktør for eksterne innholdssamarbeid er Mathias Thaulow Lisberg.

© Podme AB 2024